HEPATIC GLUCOSE-PRODUCTION DURING INTRAPERITONEAL AND INTRAVENOUS CLOSED-LOOP INSULIN REGULATION OF BLOOD-GLUCOSE IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS
Jj. Robert et al., HEPATIC GLUCOSE-PRODUCTION DURING INTRAPERITONEAL AND INTRAVENOUS CLOSED-LOOP INSULIN REGULATION OF BLOOD-GLUCOSE IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS, Diabetologia, 36(11), 1993, pp. 1185-1190
Citations number
43
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Intraperitoneal infusion of insulin should be more physiological than
intravenous insulin since part of the insulin is directed toward the p
ortal vein, which allows the liver to retain its major role in glucose
homeostasis. The regulation of hepatic glucose production during the
intraperitoneal and intravenous infusions of insulin were compared in
eight Type 1 (insulin-dependent), C-peptide-deficient diabetic patient
s. Primed, continuous infusions of [6,6-H-2] glucose were given in the
postabsorptive state and during continuous infusion of unlabelled glu
cose at 1.5 and 4 mg/kg . min, while normoglycaemia was maintained by
closed-loop intraperitoneal and intravenous insulin delivery. During a
ll three periods, plasma glucose concentrations remained near normal (
variations 3.8-6.1%). The insulin infusion rates required for normal p
lasma glucose concentrations were essentially the same for the intrave
nous and intraperitoneal routes in all cases, although the variations
were greater with intraperitoneal insulin. Plasma free-insulin levels
were only slightly, non-significantly lower with intraperitoneal infus
ion than with intravenous infusion. Hepatic glucose production was sig
nificantly lower with intraperitoneal insulin during all three conditi
ons: basal: 1.71 +/- 0.14, i. p. vs 2.37 +/- 0.26 mg/kg . min, i.v.; 1
.5 mg/kg . min glucose infusion: 0.49 +/- 0.23, i.p. vs 0.88 +/- 0.18
mg/kg . min, i.v.; 4 mg/kg . min glucose infusion: 0.31 +/- 0.10, i.p.
vs 0.56 +/- 0.12 mg/kg . min, i.v.. These results, obtained with stea
dy-state conditions for plasma glucose, isotopic plasma glucose enrich
ments and unlabelled glucose infusion rates, suggest that better contr
ol of hepatic glucose production leading to normoglycaemia was achieve
d with the intraperitoneal infusion.